Related Experiment Video
Updated: Jul 18, 2026
12:49
Mutagenesis and Analysis of Genetic Mutations in the GC-rich KISS1 Receptor Sequence Identified in Humans with Reproductive Disorders
Published on: September 4, 2011
Mutations in the Gs alpha gene causing hormone resistance.
Giovanna Mantovani1, Anna Spada
1Endocrine Unit, Department of Medical Sciences, University of Milan, Fondazione Ospedale Maggiore, Policlinico, Mangiagalli e Regina Elena IRCCS, Via F. Sforza, 35, 20122 Milan, Italy. giovanna.mantovani@unimi.it
Best Practice & Research. Clinical Endocrinology & Metabolism
|December 13, 2006
Summary
Mutations in the Gsalpha gene (GNAS1) cause hormone resistance syndromes like pseudohypoparathyroidism. Loss-of-function mutations in GNAS1 lead to endocrine disorders by affecting hormone signaling pathways.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- G-protein-coupled receptors (GPCRs) and G proteins are crucial for hormone signaling in endocrinology.
- Mutations in genes encoding these proteins can lead to endocrine disorders.
- The Gsalpha gene (GNAS1) is uniquely associated with endocrine disorders through its role in cyclic AMP (cAMP) pathways.
Purpose of the Study:
- This review focuses on inactivating mutations of the GNAS1 gene.
- It examines how these mutations lead to hormone resistance syndromes.
- Specifically, it discusses pseudohypoparathyroidism types Ia and Ib.
Main Methods:
- Review of existing literature on GNAS1 mutations and endocrine disorders.
- Analysis of the molecular mechanisms underlying Gsalpha protein function.
- Correlation of genetic mutations with clinical phenotypes of hormone resistance.
Main Results:
- Heterozygous loss-of-function mutations in the maternal GNAS1 allele cause resistance to hormones mediated by Gsalpha-coupled GPCRs.
- Somatic gain-of-function mutations in GNAS1 are linked to endocrine cell proliferation.
- Inactivating mutations are the primary focus for understanding hormone resistance syndromes.
Conclusions:
- GNAS1 mutations are a significant cause of endocrine disorders, particularly hormone resistance.
- Understanding these mutations is key to diagnosing and managing conditions like pseudohypoparathyroidism.
- Further research into GNAS1 function can elucidate complex endocrine signaling.
More Related Videos
Related Concept Videos
02:38The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:39Mutations
Overview
01:22Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
01:33Cancer-Critical Genes I: Proto-oncogenes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...